Publications by authors named "Cesar Serrano"

Claim this Profile
G
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review.
César Serrano, Sebastian Bauer, Jean-Yves Blay, Paolo G Casali, Carlo M Cicala

JAMA Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MITF regulates autophagy and extracellular vesicle cargo in gastrointestinal stromal tumors.
Elizabeth Proaño-Pérez, Eva Serrano-Candelas, Mario Guerrero, David Gómez-Peregrina, Carlos Llorens, César Serrano

Mol Biomed· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEOM-AEEMT consensus on occupational cancer and cancer-associated disability.
Laura Mezquita, Mª Teófila Vicente-Herrero, Patricia Cruz, Mª Victoria Ramírez Íñiguez de la Torre, Julia Hidalgo-Coloma, César Serrano

Clin Transl Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal Stromal Tumor: Current Approaches and Future Directions in the Treatment of Advanced Disease.
Carlo M Cicala, Sebastian Bauer, Michael C Heinrich, César Serrano

Hematol Oncol Clin North Am· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leiomyosarcoma Therapeutic Approaches and Future Directions.
Candace L Haddox, David J Papke, César Serrano

Hematol Oncol Clin North Am· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next questions on gastrointestinal stromal tumors: unresolved challenges and future directions.
Davide Romandini, Pawel Sobczuk, Carlo M Cicala, César Serrano

Curr Opin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical study of microphthalmia-associated transcription factor inhibitor ML329 in gastrointestinal stromal tumor growth.
Mario Guerrero, Elizabeth Proaño-Pérez, Eva Serrano-Candelas, Alfonso García-Valverde, Berenice Carrillo-Rodríguez, César Serrano

Mol Ther Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas.
Kurt Statz-Geary, Andrew Elliott, Steven Bialick, César Serrano, Margaret von Mehren

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colo-colonic intussusception as an atypical initial presentation of inflammatory bowel disease.
Alex Arenas, Pablo Aguirre Arias, Diego Ruedi, César Serrano

Rev Esp Enferm Dig· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effectiveness and safety of avapritinib in real-world Spanish cases with gastrointestinal stromal tumor and D842V-PDGFRA mutation.
Isaac Nuñez Hernández, Cristina Gómez Palmero, Juan Ramón Delgado, Ana Nuño, Maria Ángeles Sala González, César Serrano

Oncologist· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEOM-GEIS Spanish clinical guidelines for the management of soft‑tissue sarcomas (2024).
César Serrano, Marta Arregui, Irene Carrasco, Nadia Hindi, Javier Martínez-Trufero

Clin Transl Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Many paths, one destination: Bridging the gap in cancer care.
Erik Sahai, Hongxia Wang, Marleen Kok, Catherine J Wu, Lin Shen, César Serrano

Cancer Cell· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging treatments for sarcoma: from 2024 onward.
Diego Gómez-Puerto, Carlo M Cicala, Claudia Valverde, César Serrano

Expert Opin Emerg Drugs· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Next-Generation Sequencing in Succinate Dehydrogenase-Deficient GI Stromal Tumor Identifies Actionable Alterations in the PI3K/mTOR Pathway.
Carlo María Cicala, Judit Matito, María Quindos, David Gómez-Peregrina, Paula Romero-Lozano, César Serrano

JCO Precis Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with exon 11 + 17/18 mutations.
Suzanne George, Jean-Yves Blay, Ping Chi, Robin L Jones, César Serrano

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA.
David Gómez-Peregrina, Carlo Maria Cicala, César Serrano

Curr Opin Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally.
Javier Carmona, Elena Chavarria, Kate Donoghue, Christina von Gertten, Petra Oberrauch, Cesar Serrano

Cancer Discov· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations.
Francisco Cristóbal Muñoz-Casares, Javier Martín-Broto, Pedro Cascales-Campos, Juan Torres-Melero, Irene López-Rojo, César Serrano

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperammonemic encephalopathy after tyrosine kinase inhibitors: A literature review and a case example.
Héctor Carlos García-Díaz, Simeon Eremiev, Javier Gómez-Alonso, Joel Veas Rodriguez, Anna Farriols, César Serrano

J Oncol Pharm Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.
Thomas Mühlenberg, Johanna Falkenhorst, Tom Schulz, Benjamin S Fletcher, Alina Teuber, César Serrano

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIT/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem.
Carlo María Cicala, Iván Olivares-Rivas, Jon Ander Aguirre-Carrillo, César Serrano

Expert Opin Investig Drugs· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies.
Michael C Heinrich, Xinhua Zhang, Robin L Jones, Suzanne George, César Serrano

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.
Michael C Heinrich, Robin L Jones, Suzanne George, Hans Gelderblom, Patrick Schöffski, César Serrano

Nat Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors.
César Serrano, Sara Rothschild, Guillermo Villacampa, Michael C Heinrich, Suzanne George

Nat Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective.
Bruna Bianca Lopes David, Pedro Nazareth Aguiar Junior, Matheus Costa E Silva, Rodrigo Dienstmann, Carlos Gil Ferreira, César Serrano

JCO Glob Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis